Lack of <i>Tgfbr1</i> and <i>Acvr1b</i> synergistically stimulates myofibre hypertrophy and accelerates muscle regeneration.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35323108.
- Also identified by DOI 10.7554/eLife.77610 and PMC identifier 9005187.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In skeletal muscle, transforming growth factor-β (TGF-β) family growth factors, TGF-β1 and myostatin, are involved in atrophy and muscle wasting disorders. Simultaneous interference with their signalling pathways may improve muscle function; however, little is known about their individual and combined receptor signalling. Here, we show that inhibition of TGF-β signalling by simultaneous muscle-specific knockout of TGF-β type I receptors <i>Tgfbr1</i> and <i>Acvr1b</i> in mice, induces substantial hypertrophy, while such effect does not occur by single receptor knockout. Hypertrophy is induced by increased phosphorylation of Akt and p70S6K and reduced E3 ligases expression, while myonuclear number remains unaltered. Combined knockout of both TGF-β type I receptors increases the number of satellite cells, macrophages and improves regeneration post cardiotoxin-induced injury by stimulating myogenic differentiation. Extra cellular matrix gene expression is exclusively elevated in muscle with combined receptor knockout. <i>Tgfbr1</i> and <i>Acvr1b</i> are synergistically involved in regulation of myofibre size, regeneration, and collagen deposition.
Medical subject headings
- Muscle Development
- Muscle, Skeletal